Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting - A Cross-sectional Study of Adult Asthma Patients in Japa
- Conditions
- Asthma
- Registration Number
- JPRN-UMIN000020257
- Lead Sponsor
- AstraZeneca K.K.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1100
1.Provided written consent before starting any procedure specified in the study protocol
2.Aged 20 years or older at the time of providing the consent
3.Receiving treatment for asthma as an outpatient at the time of providing the consent
4.Physician definitive diagnosis of asthma at least 1 year before providing the consent
5.Started to receive treatment with at least 1 of the asthma drugs at least 1 year before providing the consent
1.Enrolled in this study in the past
2.Assessed by the Investigator to require additional treatment due to worsening of asthma symptoms at the time of providing the consent
3.Scheduled to be hospitalized within 2 weeks after providing the consent due to asthma or any other disease
4.Participating in another interventional study such as a clinical study at the time of providing the consent
5.Considered by the Investigator as not appropriate for enrollment in this study due to inability to adhere to the procedures, limitations, and requirements of this study including answering and returning the questionnaires, etc.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary variable is status of asthma control in each patient.
- Secondary Outcome Measures
Name Time Method 1.Asthma symptoms (e.g., intensity, frequency, and limitations on activities, etc.)<br>2.Use of drugs for the treatment of asthma<br>3.Asthma control during the past 1 week<br>4.Asthma control status during the past 1 month<br>5.QOL<br>6.Use of drugs for asthma attack and emotional feelings